Home Newsletters Mammary Cell News Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer

0
Lentiviral barcoding/single cell RNA-sequencing reveal that HER2+ breast cancer cells cycle stochastically through a “pre-drug-tolerant persister” state, characterized by a G0-like expression signature and enriched for diapause and/or senescence genes.
[Cancer Discovery]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version